Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound sodium alginate suspension vs placebo in GERD (pH monitoring)
CTR20140033Phase 3Completed
- Sponsor
- Hebikon
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium trisilicate in gastroesophageal reflux disease (GERD), sponsored by Hebikon. Started Mar 2014; status: completed.
02
Drugs
magnesium trisilicate
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on CTR20140033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140033.